Evidence map›Paper›PMID 30083817›Full record

ArticleJournal of cancer research and clinical oncology2018

Diverging impact of cell fate determinants Scrib and Llgl1 on adhesion and migration of hematopoietic stem cells.

Banaja P Dash, Tina M Schnöder, Carolin Kathner, Juliane Mohr, Sönke Weinert, Carolin Herzog, Parimala Sonika Godavarthy, Costanza Zanetti, Florian Perner, Rüdiger Braun-Dullaeus and 9 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Evidence for a nuclear role forMolecular biology of the cell · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Banaja P DashInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.
Tina M SchnöderInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.
Carolin KathnerInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.
Juliane MohrInstitute for Molecular and Clinical Immunology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Sönke WeinertDepartment of Cardiology and Angiology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Carolin HerzogDepartment of Hematology and Oncology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Parimala Sonika GodavarthyInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.
Costanza ZanettiInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.
Florian PernerInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.
Rüdiger Braun-DullaeusDepartment of Cardiology and Angiology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Björn HartlebenInstitute of Pathology, Medizinische Hochschule Hannover, Hannover, Germany.
Tobias B HuberIII Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gerd WalzDepartment of Medicine IV, Medical Center, University of Freiburg, Freiburg, Germany.
Michael NaumannInstitute for Experimental Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Sarah EllisCancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
Valera VasioukhinDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Thilo KähneInstitute for Experimental Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Daniela S KrauseInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.
Florian H HeidelInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany. Florian.Heidel@med.uni-jena.de.ORCID http://orcid.org/0000-0003-2438-1955
Otto-von-Guericke-Universität Magdeburg · DELeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEGeorg Speyer Haus · DEFred Hutch Cancer Center · USJena University Hospital · DEMedizinische Hochschule Hannover · DEPeter MacCallum Cancer Centre · AUUniversität Hamburg · DEUniversity of Freiburg · DE

Funding

Bundesministerium für Bildung und Forschung 01GM1518CDeutsche Forschungsgemeinschaft CRC1140, CRC 992Deutsche Forschungsgemeinschaft DFG HE6233/2-1Else Kröner-Fresenius-Stiftung 2012-A152Freistaat Thüringen, Wissenschaftsministerium Proexzellenz FSU-I-03/14H2020 European Research Council 616891
6 · The paper itself

Abstract

purposeCell fate determinants Scrib and Llgl1 influence self-renewal capacity of hematopoietic stem cells (HSCs). Scrib-deficient HSCs are functionally impaired and lack sufficient repopulation capacity during serial transplantation and stress. In contrast, loss of Llgl1 leads to increased HSC fitness, gain of self-renewal capacity and expansion of the stem cell pool. Here, we sought to assess for shared and unique molecular functions of Llgl1 and Scrib by analyzing their interactome in hematopoietic cells.

methodsInteractome analysis was performed by affinity purification followed by mass spectrometry. Motility, migration and adhesion were assessed on primary murine HSCs, which were isolated by FACS sorting following conditional deletion of Scrib or Llgl1, respectively. Imaging of Scrib-deficient HSCs was performed by intravital 2-photon microscopy.

resultsComparison of Scrib and Llgl1 interactome analyses revealed involvement in common and unique cellular functions. Migration and adhesion were among the cellular functions connected to Scrib but not to Llgl1. Functional validation of these findings confirmed alterations in cell adhesion and migration of Scrib-deficient HSCs in vitro and in vivo. In contrast, genetic inactivation of Llgl1 did not affect adhesion or migratory capacity of hematopoietic stem cells.

conclusionOur data provide first evidence for an evolutionarily conserved role of the cell fate determinant Scrib in HSC adhesion and migration in vitro and in vivo, a unique function that is not shared with its putative complex partner Llgl1.

Indexed as

Cell AdhesionCell LineageCell MovementAnimalsApoptosisCell DifferentiationCell ProliferationCells, CulturedCytoskeletal ProteinsHematopoietic Stem CellsHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLProtein Interaction Domains and MotifsProteomeCytoskeletal ProteinsHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsLlgl1 protein, mouseProteomescrib protein, mouseTumor Suppressor ProteinsAdhesionCell fate determinantsHematopoietic stem cellsHSCLlgl1MigrationPolarityScribble

Identifiers

PMID30083817
PMCPMC11813372
OpenAlexW2887120029

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.